Institut Toulousain des Maladies Infectieuses et Inflammatoires
  • Actualités
    • Publications
    • Séminaires
    • Soutenances de thèses
    • Faits marquants
  • L’Institut
    • Présentation
    • Enseignement
    • Organigramme
    • Nous rejoindre
    • Stagiaires
    • Les Tutelles
    • Financeurs extérieurs
    • Annuaire
  • Equipes de Recherche
    • J.C. Guéry
    • M. Simon
    • N. Gaudenzio
    • A. Saoudi / R. Liblau
    • R. Poupot / J. Ausseil
    • N. Blanchard
    • D. Dunia / C. Malnou
    • J. Izopet / B. Lagane
    • N. Jabrane-Ferrat
    • J. van Meerwijk / O. Joffre
    • N. Fazilleau / S. Guerder
    • R. Lesourne / L. Dupré
    • M. Diaz Munoz
    • L. Reber
    • C. Le Coz
    • A. Dejean
  • Plateaux Techniques
    • Cytométrie et tri cellulaire
    • Imagerie cellulaire
    • Immunomonitoring humain
    • Génomique et transcriptomique
  • Contact
  • English
Sélectionner une page
Landscape of Mast Cell Populations across Organs in Mice and Humans

Landscape of Mast Cell Populations across Organs in Mice and Humans

22 Sep 2023 | Publications

The research team of Nicolas Gaudenzio at Infinity has recently published a new article titled « Landscape of Mast Cell Populations across Organs in Mice and Humans » in The Journal of Experimental Medicine. This pioneering study stands as the very first pan-organ...
Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro

Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro

23 Sep 2022 | Publications

Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro   Mathilde Bergamelli, Hélène Martin, Yann Aubert, Jean-Michel Mansuy, Marlène Marcellin, Odile Burlet-Schiltz, Ilse Hurbain,Graça...
HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages

HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages

17 Juin 2022 | Publications

HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages Mingyu Han, Vincent Cantaloube-Ferrieu, Maorong Xie, Marie Armani-Tourret, Marie Woottum, Jean-Christophe Pagès, Philippe Colin, Bernard Lagane*, Serge Benichou*...
The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion.

The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion.

1 Mai 2022 | Publications

The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion. Worrall WPM*, Kamphuis JBJ*, Stackowicz J, Mougel A, Maure E, Pecalvel C, et al. Allergy 2022; 00:1–4.   MAR-1 est le seul anticorps monoclonal...
Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice

15 Juin 2021 | Publications

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice Conde E Bertrand R, Balbino Bonnefoy Stackowicz Caillot Colaone Hamdi Houmadi Loste Kamphuis JBJ Huetz Guilleminault Gaudenzio Mougel Hardy Snouwaert JN Koller BH Serra Bruhns...
TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women

TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women

19 Juin 2020 | Publications

TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women Pascal Azar (*), José Enrique Mejía (*), Claire Cenac (*), Arnoo Shaiykova, Ali Youness, Sophie Laffont, Asma Essat, Jacques Izopet, Caroline Passaes, Michaela Müller-Trutwin, Pierre...
« Entrées précédentes
Entrées suivantes »
Crédits et mentions légales - © Agences CosiWeb & ComScience
 
En poursuivant votre navigation sur notre site, vous acceptez l’utilisation de cookies destinés à améliorer votre expérience de navigation sur le site et à vous proposer des contenus et messages adaptés à vos besoins.J'ai comprisEn savoir plus